Gland Pharma Limited

NSE GLAND.NS

Gland Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -210.64 M

Gland Pharma Limited Net Cash Used For Investing Activities is USD -210.64 M for the year ending March 31, 2024, a -243.29% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Gland Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD 147.00 M, a 211.33% change year over year.
Gland Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -132.05 M, a 36.56% change year over year.
Gland Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -208.13 M, a -104.74% change year over year.
Gland Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -101.66 M, a -124.89% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

NSE: GLAND.NS

Gland Pharma Limited

CEO	Mr. Shyamakant Giri
IPO Date	Nov. 20, 2020
Location	India
Headquarters	Plot No. 11 & 84, TSIIC Phase: IV
Employees	4,217
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Key trends

Past 5 years